Synthesis and evaluation of novel potential HCV helicase inhibitors

被引：0
|
作者：
Brancale, A
Vlachakis, D
Barbera, MC
Silvestri, R
Berry, C
Neyts, J
机构：
[1] Cardiff Univ, Welsh Sch Pharm, Cardiff CF10 3XF, Wales
[2] Univ Roma La Sapienza, Dipartimento Farmaceut, I-00185 Rome, Italy
[3] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3US, Wales
[4] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium
来源：
ANTIVIRAL RESEARCH | 2006年 / 70卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：A53 / A54
页数：2
相关论文
共 50 条
  • [1] Synthesis and evaluation of novel HCV replication inhibitors
    McGowan, David C.
    Khamlichi, Mourad D.
    De Groot, Alex
    Pauwels, Frederik
    Delouvroy, Frederic
    Van Emelen, Kristof
    Simmen, Kenneth
    Raboisson, Pierre
    [J]. MOLECULAR DIVERSITY, 2017, 21 (02) : 475 - 481
  • [2] Synthesis and evaluation of novel HCV replication inhibitors
    David C. McGowan
    Mourad D. Khamlichi
    Alex De Groot
    Frederik Pauwels
    Frédéric Delouvroy
    Kristof Van Emelen
    Kenneth Simmen
    Pierre Raboisson
    [J]. Molecular Diversity, 2017, 21 : 475 - 481
  • [3] Design, synthesis and evaluation of a novel series of BLM helicase inhibitors
    Ali, Yusuf
    Chen, Xiangrong
    Ward, Simon
    Pearl, Frances
    [J]. CANCER RESEARCH, 2017, 77
  • [4] Synthesis and evaluation of novel potent HCV NS5A inhibitors
    Zhang, Hongwang
    Zhou, Longhu
    Amblard, Franck
    Shi, Junxing
    Bobeck, Drew R.
    Tao, Sijia
    McBrayer, Tamara R.
    Tharnish, Phillip M.
    Whitaker, Tony
    Coats, Steven J.
    Schinazi, Raymond F.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (14) : 4864 - 4868
  • [5] Design, synthesis and molecular docking of novel triazole derivatives as potential CoV helicase inhibitors
    Zaher, Nashwa Hafez
    Mostafa, Mohammed Ismail
    Altaher, Abdullah Yousef
    [J]. ACTA PHARMACEUTICA, 2020, 70 (02) : 145 - 159
  • [6] Synthesis and biological evaluation of novel pentacyclic triterpene α-cyclodextrin conjugates as HCV entry inhibitors
    Xiao, Sulong
    Wang, Qi
    Si, Longlong
    Zhou, Xiaoshu
    Zhang, Yongmin
    Zhang, Lihe
    Zhou, Demin
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 124 : 1 - 9
  • [7] Straightforward synthesis of triazoloacyclonucleotide phosphonates as potential HCV inhibitors
    Elayadi, Hanane
    Smietana, Michael
    Pannecouque, Christophe
    Leyssen, Pieter
    Neyts, Johan
    Vasseur, Jean-Jacques
    Lazrek, Hassan B.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (24) : 7365 - 7368
  • [8] An assay for the biological testing of potential inhibitors for the HCV helicase, dengue virus helicase and dengue virus helicase/protease complex (NS3 domain)
    Vlachakis, DP
    Berry, C
    Jones, G
    Brancale, A
    [J]. ANTIVIRAL RESEARCH, 2005, 65 (03) : A60 - A60
  • [9] Novel methods for the synthesis of 1,5,2-diazaphosphinines as potential inhibitors of HCV polymerase
    Da Costa, Daniel
    Roland, Arlene
    Dousson, Cyril B.
    [J]. TETRAHEDRON LETTERS, 2017, 58 (03) : 194 - 196
  • [10] Synthesis and in vitro evaluation of novel rhodanine derivatives as potential cholinesterase inhibitors
    Kratky, Martin
    Stepankova, Sarka
    Vorcakova, Katarina
    Vinsova, Jarmila
    [J]. BIOORGANIC CHEMISTRY, 2016, 68 : 23 - 29
12345